What will Roche end up paying for Genentech?

[Joelle]

What will Roche end up paying for Genentech?
      


The first lawsuits are flying but Roche's experienced dealmakers are unlikely to put more cash on the table just yet.
While it seems clear $89 a share won't do it -- the market has already pushed Genentech stock to $95 and some analysts are talking well over $100 -- the Basel-based drugs giant can afford to bide its time. With 56 percent of the [...]
         

You are not allowed to view links. Register or Login